Line 10: |
Line 10: |
| ==General Disease Overview / Description of Cancer Category== | | ==General Disease Overview / Description of Cancer Category== |
| | | |
− | Splenic B-cell lymphoma/leukemia, Unclassifiable (SBLL-U) includes primary splenic lymphomas that cannot be better classified into other [[Mature B-Cell Neoplasms|mature B-cell neoplasms]] and are overall rare, accounting for <1% of lymphomas. Two entities in this category, [[Hairy Cell Leukemia Variant|hairy cell leukemia variant]] (HCL-v) and [[Splenic Diffuse Red Pulp Small B-cell Lymphoma|splenic diffuse red pulp small B-cell lymphoma]] (SDRPL) may represent distinct entities and are designated as provisional entities in the 2017 WHO. Recent molecular evidence suggests that they are distinct from each other and from [[Splenic Marginal Zone Lymphoma|splenic marginal zone lymphoma]] and [[Hairy Cell Leukemia|hairy cell leukemia]], which which the have overlapping clinical, morphologic, and immunophenotypic features. Primary splenic lymphomas that cannot be classified as HCL-v or SDRPL should be classified as splenic B-cell lymphoma/leukemia, Unclassifiable. | + | Splenic B-cell lymphoma/leukemia, Unclassifiable (SBLL-U) includes primary splenic lymphomas that cannot be better classified into other [[HAEM4:Mature B-Cell Neoplasms|mature B-cell neoplasms]] and are overall rare, accounting for <1% of lymphomas. Two entities in this category, [[HAEM5:Splenic B-cell lymphoma/leukaemia with prominent nucleoli|hairy cell leukemia variant]] (HCL-v) and [[HAEM5:Splenic diffuse red pulp small B-cell lymphoma|splenic diffuse red pulp small B-cell lymphoma]] (SDRPL) may represent distinct entities and are designated as provisional entities in the 2017 WHO. Recent molecular evidence suggests that they are distinct from each other and from [[HAEM5:Splenic marginal zone lymphoma|splenic marginal zone lymphoma]] and [[HAEM5:Hairy cell leukaemia|hairy cell leukemia]], which which the have overlapping clinical, morphologic, and immunophenotypic features. Primary splenic lymphomas that cannot be classified as HCL-v or SDRPL should be classified as splenic B-cell lymphoma/leukemia, Unclassifiable. |
| | | |
| ==WHO Classification Pages (Includes Links to Content)== | | ==WHO Classification Pages (Includes Links to Content)== |
| | | |
− | * [[Splenic Diffuse Red Pulp Small B-cell Lymphoma]] | + | * [[HAEM5:Splenic diffuse red pulp small B-cell lymphoma]] |
− | * [[Hairy Cell Leukemia Variant]] | + | * [[HAEM5:Splenic B-cell lymphoma/leukaemia with prominent nucleoli]] |
| | | |
| ==Other Related Pages (Includes Links to Content)== | | ==Other Related Pages (Includes Links to Content)== |
Line 21: |
Line 21: |
| Differential diagnosis: other small B-cell lymphomas with cytoplasmic projections and significant splenic involvement | | Differential diagnosis: other small B-cell lymphomas with cytoplasmic projections and significant splenic involvement |
| | | |
− | * [[Splenic Marginal Zone Lymphoma]] | + | * [[HAEM5:Splenic marginal zone lymphoma]] |
− | * [[Hairy Cell Leukemia]] | + | * [[HAEM5:Hairy cell leukaemia]] |
| | | |
| ==Additional Information== | | ==Additional Information== |